Oncology Medical News about Adenocarcinoma Adenocarcinoma, Bronchiolo-Alveolar Lung Neoplasms

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lung Adenocarcinoma with EGFR Amplification Has Distinct Clinicopathologic and Molecular Features in Never-Smokers
Cancer Research, 11/02/09

Sholl LM et al. – Lung adenocarcinomas with EGFR amplification have a unique association with exon 19 deletion mutations and show distinct clinicopathologic features associated with a significantly worsened prognosis. In these cases, EGFR amplification is heterogeneously distributed, mostly in areas with a solid histology.

<< Previous
Role for Kruppel-Like Factor 4 in Determining the Outcome of p53...

Next >>
A novel thromboxane A2 receptor D304N variant which abrogates...

Use of EGFR/KRAS Mutation Testing To Define Clonal Relationships Among Multiple Lung Adenocarcinomas
Chest, 10/08/09 Relevance Score: 93%

Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas
Lung Cancer, 11/06/09 Relevance Score: 89%

Diagnostic Efficacy of PET/CT Plus Brain MR Imaging for Detection of Extrathoracic Metastases in Patients with Lung Adenocarcinoma
Journal of Korean Medical Science, 11/16/09 Relevance Score: 83%

An Embryonic Stem Cell–Like Signature Identifies Poorly Differentiated Lung Adenocarcinoma but not Squamous Cell Carcinoma
Clinical Cancer Research, 10/12/09 Relevance Score: 82%

Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas
Modern Pathology, 10/28/09 Relevance Score: 81%